0001415889-21-000903.txt : 20210223 0001415889-21-000903.hdr.sgml : 20210223 20210223191818 ACCESSION NUMBER: 0001415889-21-000903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210219 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wellisch Alejandro D CENTRAL INDEX KEY: 0001717526 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 21667772 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232021_040255.xml X0306 4 2021-02-19 0000001800 ABBOTT LABORATORIES ABT 0001717526 Wellisch Alejandro D 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false SENIOR VICE PRESIDENT Option (right to buy) 124.04 2021-02-19 4 A 0 39994 0 A 2022-02-19 2031-02-18 Common Shares 39994 39994 D Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,331 on February 19, 2022, 13,331 on February 19, 2023, and 13,332 on February 19, 2024. /s/ Alejandro D. Wellisch by Jessica H. Paik, Attorney-in-Fact 2021-02-23